CHE logo

Chemed (CHE)

Profile

Full Name

Chemed Corporation

Ticker Symbol

CHE

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

May 3, 1973

Indexes

Not included

Website

http://www.chemed.com

Employees

15695

Key Details

Price

$600.69(+1.23%)

Market cap

$8.79B(Mid cap)

Last Dividend

$0.50

TTM Dividend yield

0.32%

Annual revenue

$2.43B(+7.37% YoY)

Annual EPS

$19.89(+10.93% YoY)

PE ratio

30.17

Next earnings date

Apr 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$600.69
CHE price is $600.69

30-Day Relative Volume

0.69
CHE 30-day relative volume is 0.69

Price Performance

Price Most recent change

+1.23%
CHE price was up +1.23% on Apr 14, 2025

Price YTD change

+13.38%
CHE price is up +13.38% since January 1st

Price 1-year change

-2.88%
CHE price is down -2.88% year-on-year

Price 3-year change

+20.48%
CHE price is up +20.48% over the past 3 years

Price Range

Price All-time high

$654.62
CHE price is currently -8.24% below its historical high of $654.62

Price 3-year low

$430.16
CHE price is currently +39.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.79B
CHE market capitalization is $8.79 billion

Market cap 3-year change

+17.81%
CHE market capitalization is up +17.81% over the past 3 years

Market cap All-time high

$9.83B
CHE market capitalization is currently -10.58% below its historical high of $9.83 billion

Market cap sector rank

91.94%
CHE market capitalization is higher than 91.94% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.97%
CHE shares outstanding is down -2.97% year-on-year

Shares Outstanding 3-Year Change

-2.21%
CHE shares outstanding is down -2.21% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.30
CHE beta is 0.30

200-day SMA

$567.60
CHE price is currently +5.83% above its 200-day simple moving average

50-day SMA

$583.26
CHE price is currently +2.99% above its 50-day simple moving average

RSI

53.59
CHE 14-day relative strength index is 53.59

Volume

0.69
CHE 30-day relative volume is 0.69

ATR

$16.33
CHE average true range is $16.33

10-day Historical Volatility

32.55%
CHE 10-day historical volatility is 32.55%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.50
CHE last dividend was $0.50 per share, with an ex-dividend date of February 24, 2025

Next Dividend

-
CHE next dividend has not yet been announced

Dividend per share

Dividend per share

$1.80
CHE annual dividend per share is $1.80

Dividend per share Sector Rank

67.44%
CHE annual dividend per share is higher than 67.44% of companies in Healthcare sector

Dividend per share 1-Year Change

+15.38%
CHE annual dividend per share is up +15.38% year-on-year

Dividend per share 3-Year Change

+28.57%
CHE annual dividend per share is up +28.57% over the past 3 years

Dividend yield

Dividend yield

0.30%
CHE annual dividend yield is 0.30%

Dividend yield Sector Rank

7.06%
CHE annual dividend yield is higher than 7.06% of companies in Healthcare sector

Other

Payout ratio

8.97%
CHE annual payout ratio is 8.97%

Dividends paid

$27.09M
CHE annual dividends paid is $27.09 million

Free cash flow

$367.97M
CHE annual free cash flow is $367.97 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.43B
CHE annual revenue is $2.43 billion

Revenue Analysts estimate

$2.62B
CHE annual revenue is currently -7.38% lower than the consensus analysts' forecast

Revenue 1-year change

+7.37%
CHE annual revenue is up +7.37% year-on-year

Revenue Sector rank

86.45%
CHE annual revenue is higher than 86.45% of companies in Healthcare sector

EPS

EPS

$19.89
CHE annual earnings per share is $19.89

EPS Analysts estimate

$25.19
CHE annual earnings per share is currently -21.04% lower than the consensus analysts' forecast

EPS 1-year change

+10.93%
CHE annual earnings per share is up +10.93% year-on-year

EPS Sector rank

99.17%
CHE annual earnings per share is higher than 99.17% of companies in Healthcare sector

Profit

Gross profit

$854.35M
CHE annual gross profit is $854.35 million

Gross margin

35.14%
CHE annual gross profit margin is 35.14%

Operating profit

$366.94M
CHE annual operating income is $366.94 million

Operating margin

15.09%
CHE annual operating profit margin is 15.09%

Net income

$302.00M
CHE annual net profit is $302.00 million

Net margin

12.42%
CHE annual net profit margin is 12.42%

Expenses

Total expenses

$2.06B
CHE annual total expenses is $2.06 billion

Operating expenses

$487.41M
CHE annual total operating expenses is $487.41 million

Cost of goods sold

$1.58B
CHE annual cost of goods sold is $1.58 billion

Selling, general & administrative expenses

$424.36M
CHE annual SGA is $424.36 million

Depreciation and amortization

$63.05M
CHE annual depreciation & amortization is $63.05 million

Interest expense

$1.78M
CHE annual interest expense is $1.78 million

Income tax

$97.47M
CHE annual income tax is $97.47 million

EBIT & EBITDA

EBIT

$401.25M
CHE annual earnings before interest & taxes is $401.25 million

EBITDA

$464.29M
CHE annual EBITDA is $464.29 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.67B
CHE annual total assets is $1.67 billion

Non current assets

$1.27B
CHE annual long term assets is $1.27 billion

Current assets

$394.75M
CHE annual total current assets is $394.75 million

Cash and cash equivalents

$178.35M
CHE annual cash & cash equivalents is $178.35 million

Accounts receivable

$171.16M
CHE annual accounts receivable is $171.16 million

Inventory

$8.19M
CHE annual inventory is $8.19 million

Liabilities

Total liabilities

$549.58M
CHE annual total liabilities is $549.58 million

Long term liabilities

$263.89M
CHE annual total long term liabilities is $263.89 million

Current liabilities

$285.69M
CHE annual total current liabilities is $285.69 million

Accounts payable

$44.15M
CHE annual accounts payable is $44.15 million

Debt

Total debt

$140.84M
CHE annual total debt is $140.84 million

Total debt 1-year change

+1.03%
CHE annual total debt is up +1.03% year-on-year

Long term debt

$98.54M
CHE annual long term debt is $98.54 million

Short term debt

$42.31M
CHE annual short term debt is $42.31 million

Equity & Capital

Shareholders equity

$1.12B
CHE annual stockholders equity is $1.12 billion

Book value

$1.12B
CHE annual book value is $1.12 billion

Retained earnings

$2.72B
CHE annual retained earnings is $2.72 billion

Working capital

$109.05M
CHE annual working capital is $109.05 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$417.50M
CHE annual cash flow from operations is $417.50 million

Cash from operations 1-year change

+26.4%
CHE annual cash flow from operations is up +26.4% year-on-year

Cash from investing

-$143.91M
CHE annual cash flow from investing activities is -$143.91 million

Cash from investing 1-year change

-137.31%
CHE annual cash flow from investing activities is down -137.31% year-on-year

Cash from financing

-$359.19M
CHE annual cash flow from financing activities is -$359.19 million

Cash from financing 1-year change

-349.98%
CHE annual cash flow from financing activities is down -349.98% year-on-year

CAPEX

CAPEX

$49.53M
CHE annual capital expenditures is $49.53 million

CAPEX 1-year change

-12.88%
CHE annual capital expenditures is down -12.88% year-on-year

Free Cash Flow

Free cash flow

$367.97M
CHE annual free cash flow is $367.97 million

Free cash flow 1-year change

+34.57%
CHE annual free cash flow is up +34.57% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

35.14%
CHE annual gross profit margin is 35.14%

Operating margin

15.09%
CHE annual operating profit margin is 15.09%

Net margin

12.42%
CHE annual net profit margin is 12.42%

ROA & ROE

ROA

18.10%
CHE annual return on assets is 18.10%

ROE

27.12%
CHE annual return on equity is 27.12%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

30.17
CHE price to earnings ratio is 30.17

PE ratio Sector rank

60.78%
CHE price to earnings ratio is higher than 60.78% of companies in Healthcare sector

PB Ratio

PB ratio

7.86
CHE price to book ratio is 7.86

PB ratio Sector rank

90.21%
CHE price to book ratio is higher than 90.21% of companies in Healthcare sector

PS Ratio

PS ratio

3.62
CHE price to sales ratio is 3.62

PS ratio Sector rank

58.33%
CHE price to sales ratio is higher than 58.33% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.75B
CHE enterprise value is $8.75 billion

Enterprise value Sector rank

91.07%
CHE enterprise value is higher than 91.07% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.86
CHE EV/EBITDA is 18.86

EV/EBITDA Sector rank

90.96%
CHE EV/EBITDA is higher than 90.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.38
CHE annual current ratio is 1.38

Quick ratio

1.35
CHE annual quick ratio is 1.35

Leverage

Debt to equity

0.00
CHE annual debt to equity ratio is 0.00

Interest coverage ratio

225.42
CHE annual interest coverage ratio is 225.42

Risk & Stability

Piotroski F-Score

6
CHE piotroski f-score is 6

Altman Z-Score

14.21
CHE altman z-score is 14.21

Analyst ratings

Recent major analysts updates

Mar 14, 25 RBC Capital
Outperform
Nov 5, 24 RBC Capital
Outperform
May 21, 24 RBC Capital
Outperform
Mar 4, 24 RBC Capital
Outperform
Feb 29, 24 Oppenheimer
Outperform
Jan 17, 24 Oppenheimer
Outperform
Oct 30, 23 RBC Capital
Outperform
Jul 31, 23 RBC Capital
Outperform
Jul 27, 23 Oppenheimer
Outperform
May 1, 23 RBC Capital
Outperform

Institutional Ownership

Similar stocks

VTRS logo
Viatris (VTRS)
QGEN logo
Qiagen NV (QGEN)
TECH logo
Bio-Techne (TECH)
MASI logo
Masimo (MASI)
MEDP logo
Medpace Holdings (MEDP)
ASND logo
Ascendis Pharma A/S (ASND)
EXAS logo
Exact Sciences (EXAS)
WBA logo
Walgreens Boots Alliance (WBA)
HSIC logo
Henry Schein (HSIC)
  • What is the ticker symbol for Chemed?
  • Does Chemed pay dividends?
  • What sector is Chemed in?
  • What industry is Chemed in?
  • What country is Chemed based in?
  • When did Chemed go public?
  • Is Chemed in the S&P 500?
  • Is Chemed in the NASDAQ 100?
  • Is Chemed in the Dow Jones?
  • When was Chemed's last earnings report?
  • When does Chemed report earnings?
  • Should I buy Chemed stock now?

What is the ticker symbol for Chemed?

The ticker symbol for Chemed is NYSE:CHE

Does Chemed pay dividends?

Yes, Chemed pays dividends. The last payment was $0.50, with an ex-dividend date on February 24, 2025

What sector is Chemed in?

Chemed is in the Healthcare sector

What industry is Chemed in?

Chemed is in the Medical Care Facilities industry

What country is Chemed based in?

Chemed is headquartered in United States

When did Chemed go public?

Chemed's initial public offering (IPO) was on May 3, 1973

Is Chemed in the S&P 500?

No, Chemed is not included in the S&P 500 index

Is Chemed in the NASDAQ 100?

No, Chemed is not included in the NASDAQ 100 index

Is Chemed in the Dow Jones?

No, Chemed is not included in the Dow Jones index

When was Chemed's last earnings report?

Chemed's most recent earnings report was on Feb 26, 2025

When does Chemed report earnings?

The next expected earnings date for Chemed is Apr 23, 2025

Should I buy Chemed stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page